| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3276698
Max Phase: Preclinical
Molecular Formula: C11H17Br
Molecular Weight: 229.16
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: BrC12CCCC3CC(CCC31)C2
Standard InChI: InChI=1S/C11H17Br/c12-11-5-1-2-9-6-8(7-11)3-4-10(9)11/h8-10H,1-7H2
Standard InChI Key: SMRZBUXTCBUQMD-UHFFFAOYSA-N
Associated Targets(non-human)
Newcastle disease virus (78 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 229.16 | Molecular Weight (Monoisotopic): 228.0514 | AlogP: 3.74 | #Rotatable Bonds: 0 |
| Polar Surface Area: 0.00 | Molecular Species: | HBA: 0 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 0 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.64 | CX LogD: 3.64 |
| Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.55 | Np Likeness Score: 1.44 |
References
| 1. Aigami K, Inamoto Y, Takaishi N, Fujikura Y.. (1976) Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives., 19 (4): [PMID:1263206] [10.1021/jm00226a018] |
Source
Source(1):